ERVIN GRAVES STRATEGY GROUP, LLC for EMERGENT BIOSOLUTIONS INC.
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Disaster Planning/Emergencies DIS
State Opioid Response Grants funding; Substance Abuse and Mental Health Block Grant funding; CARA 3.0 - Comprehensive Addiction and Recovery Act; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; H.R. 2379 The State Opioid Response Grant Authorization Act of 2021; Appropriations funding for Fiscal Year 2022; NDAA for Fiscal Year 2022- provisions related to biological and chemical defense and access to naloxone; S.4231 - Preparing for the Next Pandemic Act; H.R 2366 S.1457 - Stop Fentanyl Act; H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines;
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES L ERVIN | — |
| COLBY MILLER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.